Zach Zalewski is a Senior Director of Policy at the Association for Accessible Medicines. A trained scientist and lawyer, he brings extensive subject matter expertise and strategic acumen to the AAM team. Most recently, he served as Enterprise Strategy Director at the United States Pharmacopeia (USP), advising executive and functional leadership on enterprise growth and mission impact.
Previously, Zach worked as a consultant at Avalere Health, advising various clients on FDA regulatory strategy and market access issues. Zach holds a PhD in Molecular and Human Genetics from Baylor College of Medicine and a JD from Case Western Reserve University.
